WUXI

wuxibiologics.com · Wuxi, China

WuXi Biologics is a global contract research, development, and manufacturing organization (CRDMO) that provides end-to-end services for biologics, including discovery, cell line development, process development, clinical and commercial manufacturing. It serves pharmaceutical and biotechnology companies worldwide, generating revenue through fee-for-service and long-term outsourcing and manufacturing contracts. The company supports monoclonal antibodies, bispecifics, recombinant proteins, vaccines, and other biologic modalities across the full product lifecycle.

  • IT Consulting & Implementation
Revenue
$2.3B
Employees
11,000
Founded
2010
Headquarters
Wuxi, China

What 19 Arbolus experts think of WUXI

NPS distribution: 28% scored 10, 22% scored 9, 17% scored 8, with a remaining spread from 3 to 7. Renewal intent is positive, with 7 out of 9 responses indicating 'Yes,' 4 'Not Sure,' and 1 'No' (corresponding to an offboarding implementation stage and low NPS). Stickiness is high, as 78% of respondents have used the service for more than 1 year. Key drivers of positive sentiment include long-term platform use, value perception among high spenders, and strong repeat intent in larger pharma firms.Overall Customer Sentiment: Positive

Who reviewed WUXI

Total customers 19 15 current · 4 former
Reviews growth +8 in six months
Seniority of respondents
  • C-Suite 58% (11)
  • Director 42% (8)
Generalist Leader C-Suite NPS 10
Strategy Partner C-Suite NPS 10 Undecided
Other Analyst Director NPS 8

Employer names and spend open once the report publishes.

Tell us when the WUXI report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

21 Net Promoter Score, from 19 scored reviews
  • Promoters 9
  • Passives 5
  • Detractors 5

Cumulative NPS by month

+0 over 6 months
  • Jan 8
  • Feb 8
  • Apr 8
  • May 8
  • Jul 8
  • Sep 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 21 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 50%
  • Will renew 6
  • Undecided 5
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 43% 7 answers
  • Director 60% 5 answers
  • 7.8/10 Average score from customers who will renew
  • 7/10 Average score from undecided customers
  • 3/10 Average score from customers not renewing

For people who use WUXI

Do you use WUXI at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 19 customers of WUXI have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.